Changes in pediatric health-related quality of life in cystic fibrosis after IV antibiotic treatment for pulmonary exacerbations. - Wikidata - awgldk - TriplyDB

Changes in pediatric health-related quality of life in cystic fibrosis after IV antibiotic treatment for pulmonary exacerbations.

Changes in pediatric health-related quality of life in cystic fibrosis after IV antibiotic treatment for pulmonary exacerbations.

http://www.wikidata.org/entity/Q33762863

about

Application of dyadic data analysis in pediatric psychology: cystic fibrosis health-related quality of life and anxiety in child-caregiver dyads.Relationships among health-related quality of life, pulmonary health, and newborn screening for cystic fibrosis Iron homeostasis during cystic fibrosis pulmonary exacerbation Nutritional status is associated with health-related quality of life in children with cystic fibrosis aged 9-19 years.Use of a Multiplex Transcript Method for Analysis of Pseudomonas aeruginosa Gene Expression Profiles in the Cystic Fibrosis Lung Quality of life in clinical trials for children.Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation.

P2860

Q34241514-C95965F0-2BAB-40DF-93CD-E3055420C8BE Q35088797-F535A27F-B7D1-476F-83D5-CB0159AC8DF9 Q36165392-9EFEBF8E-174D-4CE2-BDF2-AB3E10368685 Q36930391-FEE3B424-31AC-46A7-A43D-0E7746540FA8 Q37287175-B479394B-664C-4697-944B-DE4417E2FADD Q37811975-D4B5447B-7E91-4488-A21B-C182F21C73D4 Q45884912-3199FCF4-9463-42CC-A554-F6484C15BA8E

P2860

Changes in pediatric health-related quality of life in cystic fibrosis after IV antibiotic treatment for pulmonary exacerbations.

http://www.wikidata.org/entity/Q33762863

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Changes in pediatric health-re ...... t for pulmonary exacerbations.

@ast

Changes in pediatric health-re ...... t for pulmonary exacerbations.

@en

type

label

Changes in pediatric health-re ...... t for pulmonary exacerbations.

@ast

Changes in pediatric health-re ...... t for pulmonary exacerbations.

@en

prefLabel

Changes in pediatric health-re ...... t for pulmonary exacerbations.

@ast

Changes in pediatric health-re ...... t for pulmonary exacerbations.

@en

P1433

Q33762863-9EAF0A38-D3C0-4C7C-946B-9E01D89A26B3

P1476

Q33762863-55F75502-B58F-433E-BF7E-F6E469D1175B

P2093

Q33762863-48A6F637-CCFA-40E4-A17B-E4E54715FDEF

Q33762863-C0133D95-D4EB-4860-AEB7-0ED3C6EB896F

Q33762863-CC522C3D-2EE2-4F06-9AB1-11C7BF79D698

Q33762863-D25F8088-B300-487F-BD5F-FD42123618F1

Q33762863-DC58EA34-22E3-4C8A-B458-622AE7482E83

P2860

Q33762863-0E8B7E1A-464A-49B2-BEAD-1DC90419287B

Q33762863-1722EBE1-DA5B-46BC-AF4E-0FDE004E2DC6

Q33762863-3944D098-A6B5-4260-A4D9-010382A6BFBD

Q33762863-5022A340-7926-4C66-86C9-19EE2389419B

Q33762863-50E35407-B354-4117-BF41-931EBC6D5453

Q33762863-70A5EF6F-162A-4065-BA5B-F214E80282FF

Q33762863-7603B170-3DE8-4D9F-865A-F580AFD0B291

Q33762863-79F4CFA8-57BC-4B76-BEEB-D1AE89B13E8D

Q33762863-7FFCE1DB-AE90-4CF1-B57D-1C2BD37E4226

Q33762863-824C9CD1-D7AE-4C50-B4C6-EAC881FBA96C

P2888

Q33762863-A7A68298-04DF-4906-B1A4-B2A5B75CFB19

P304

Q33762863-34776B8B-F1AD-4B57-A362-17183832B13F

P31

Q33762863-51D11221-CA34-4643-B4FD-B7BD96326D57

P356

Q33762863-C61D2198-6CEF-41E6-8DAF-564614CF9D6A

P433

Q33762863-D05F27F2-2072-454E-9B56-69F25E14BC80

P478

Q33762863-07A448BE-BDB1-4D38-B5F8-3E60AF2E9CA0

P50

Q33762863-8C4877DC-DDD0-4FF5-A1AE-09D33E183B71

P577

Q33762863-0CCB1B6F-F852-41F8-B0DE-F41850BEB8A4

P5875

Q33762863-E75566E2-2262-4DB3-9FEB-B54469908C76

P698

Q33762863-CC856E17-BA60-41DF-895D-0A69E67B8A76

P921

Q33762863-AA812E7A-177E-45EE-8D3F-A47B4982D0EA

P932

Q33762863-B05068EF-0E6B-4631-AB07-53DEEEBD5CEC

P356

S10880-009-9179-2

P1433

Journal of Clinical Psychology in Medical Settings

P1476

Changes in pediatric health-re ...... t for pulmonary exacerbations.

@en

P2093

Alexandra L Quittner

http://www.w3.org/2001/XMLSchema#string

Avani C Modi

http://www.w3.org/2001/XMLSchema#string

Carrie Piazza-Waggoner

http://www.w3.org/2001/XMLSchema#string

Crystal S Lim

http://www.w3.org/2001/XMLSchema#string

Jamie Wooldridge

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

Predictive 5-year survivorship model of cystic fibrosis.

Making sense of quality-of-life data.

Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection.

Measurement of health status. Ascertaining the minimal clinically important difference.

Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research.

"Specific" scale compared with "generic" scale: a double measurement of the quality of life in a French community sample of obese subjects.

Overview of published evidence on outcomes with early diagnosis from large US observational studies.

Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.

P2888

s10880-009-9179-2

P304

49-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10880-009-9179-2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Kimberly A. Driscoll

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41436179

http://www.w3.org/2001/XMLSchema#string

P698

20157799

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

2847844

http://www.w3.org/2001/XMLSchema#string